Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Palisade Bio (PALI) Return on Sales (2016 - 2025)

Historic Return on Sales for Palisade Bio (PALI) over the last 15 years, with Q3 2025 value amounting to 585.4%.

  • Palisade Bio's Return on Sales changed N/A to 585.4% in Q3 2025 from the same period last year, while for Sep 2025 it was 1433.5%, marking a year-over-year change of. This contributed to the annual value of 52.34% for FY2023, which is N/A changed from last year.
  • As of Q3 2025, Palisade Bio's Return on Sales stood at 585.4%.
  • Palisade Bio's Return on Sales' 5-year high stood at 2311.0% during Q1 2025, with a 5-year trough of 57.64% in Q2 2023.
  • For the 4-year period, Palisade Bio's Return on Sales averaged around 382.39%, with its median value being 51.16% (2021).
  • Per our database at Business Quant, Palisade Bio's Return on Sales soared by 8515100bps in 2021 and then crashed by -6291500bps in 2023.
  • Palisade Bio's Return on Sales (Quarter) stood at 117.0% in 2021, then surged by 391bps to 574.04% in 2022, then plummeted by -109bps to 52.34% in 2023, then skyrocketed by 1218bps to 585.4% in 2025.
  • Its last three reported values are 585.4% in Q3 2025, 1422.5% for Q2 2025, and 2311.0% during Q1 2025.